Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2026-01-01 @ 11:54 PM
Study NCT ID:
NCT01441635
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2011-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M12-663
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None